Asia · Wires & real time · ANI (Asian News International)
OpenAI acquires drug development platform Orchestra Bio, expands life sciences push
OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug development, as it looks to combine its artificial intelligence (AI) models…
Read the full article on ANI (Asian News International) Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.aninews.in)




